#FutureReadyHealthcare

Who We AreInvestor RelationsNewsCareers
Indegene

Cosette Pharmaceuticals chooses Indegene’s MME to assess market for 8 new cardiovascular therapies

Back to Videos

Related Insights

XyloCor chooses Indegene's MME to assess PRMA landscape for refractory angina
5:36

XyloCor chooses Indegene's MME to assess PRMA landscape for refractory angina

Let’s partner for #FutureReadyHealthcare

© 2023 Indegene. All Rights Reserved.  

Privacy PolicyCSR PolicyIndegene Speak Up